Health · Full coverage
Israeli-led study reports major breakthrough in high-risk bladder cancer treatment
How 2 Israeli newsrooms covered this story — translated into English and compared side by side.
100% right-leaning
Right 2
By דסק C14
What happened
A Shaare Zedek-led international study reports major success for a new bladder cancer treatment called NDV-01. Researchers say it produced high complete-response rates, no serious side effects, and could reshape global care if later-stage trials confirm the findings.
- 0195% of patients had complete tumor disappearance within three months.
- 0276% were cancer-free after one year, and 80% of resistant cases responded.
- 03NDV-01 uses a biodegradable gel to deliver chemotherapy inside the bladder for 14 days.
- 04No serious side effects were reported, and all patients finished treatment.
- 05The company now plans large phase 3 trials to seek global adoption.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Ask About This Story
Duki reads it, and every newsroom on the same story, then answers with sources.
Full coverage · 2 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
Related stories
Early Detection and Innovative Treatments Improve Bladder Cancer Outcomes in IsraelJun 29, 2026New Lung Cancer Drug Shows Promise, Awaiting Israeli Health Basket Inclusion4 days agoIsraeli Hospital Pioneers Alpha DaRT Therapy for Recurrent Aggressive Brain TumorsAug 13, 2026New Targeted Therapies Revolutionize Breast Cancer Treatment and Survival in IsraelJul 5, 2026Innovative Lutetium Treatment Eliminates Active Prostate Cancer in Advanced Patient at Ziv Medical CenterAug 4, 2026FDA Approves Israeli-Developed Drug Nearly Doubling Survival in Advanced Pancreatic CancerAug 27, 2026
